![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216019
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216896
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-3-2022-1659944441.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216067
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213361
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-21-2021-1626855243.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212016
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210838
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210614
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210012
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf
http://www.fiercepharma.com/manufacturing/alvogen-recalls-two-dozen-lots-nifedipine
http://www.pharma-excipients.ch/2016/04/09/preparation-and-evaluation-of-solid-dispersion-tablets-by-a-simple-and-manufacturable-wet-granulation-method-using-porous-calcium-silicate/
http://www.pharma-excipients.ch/2016/03/04/increasing-drug-solubility-with-solid-dispersions-of-silsol-6035-silica-formulated-into-sublingual-tablets/
http://www.pharma-excipients.ch/2016/03/04/preparation-and-in-vitro-evaluation-of-nifedipine-amorphous-solid-dispersions-using-mesoporous-silica-gel/
http://www.pharma-excipients.ch/2016/02/23/drug-structural-features-affect-drug-delivery-from-hyperbranched-polyesteramide-hot-melt-extrudates/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1116-2015&w=06172015&lang=eng
http://www.pharmabiz.com/NewsDetails.aspx?aid=85885&sid=1